242 related articles for article (PubMed ID: 16762146)
1. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.
Vandergheynst F; Ocmant A; Sordet C; Humbel RL; Goetz J; Roufosse F; Cogan E; Sibilia J
Clin Exp Rheumatol; 2006; 24(2):129-33. PubMed ID: 16762146
[TBL] [Abstract][Full Text] [Related]
2. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
[TBL] [Abstract][Full Text] [Related]
3. [Anti PM-Scl antibodies. Study of prevalence and of meaning].
Gaudin C; Fortenfant F; Adoue D; Beyne-Rauzy O
Rev Med Interne; 2006 Sep; 27(9):665-70. PubMed ID: 16797795
[TBL] [Abstract][Full Text] [Related]
4. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
[TBL] [Abstract][Full Text] [Related]
5. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
7. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].
Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F
Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485
[TBL] [Abstract][Full Text] [Related]
8. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
9. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
Mahler M; Greidinger EL; Szmyrka M; Kromminga A; Fritzler MJ
Ann N Y Acad Sci; 2007 Aug; 1109():311-21. PubMed ID: 17785320
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
[TBL] [Abstract][Full Text] [Related]
11. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
Lega JC; Cottin V; Fabien N; Thivolet-Béjui F; Cordier JF
J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208
[TBL] [Abstract][Full Text] [Related]
13. Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands.
García-Patos V; Bartralot R; Fonollosa V; Arnal C; Boronat M; Gelpí C; Rodríguez JL; Castells A
Br J Dermatol; 1996 Oct; 135(4):613-6. PubMed ID: 8915158
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
[TBL] [Abstract][Full Text] [Related]
15. Childhood scleromyositis with a negative PM/Scl antibody.
Marcus M; Ilyas M; Tolaymat A
Joint Bone Spine; 2010 Jan; 77(1):73-5. PubMed ID: 20022787
[TBL] [Abstract][Full Text] [Related]
16. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-/polymyositis and systemic sclerosis.
Kumánovics G; Magyarlaki T; Komócsi A; Szekeres G; Czirják L
Rheumatol Int; 2003 Jan; 23(1):6-10. PubMed ID: 12548435
[TBL] [Abstract][Full Text] [Related]
18. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
[TBL] [Abstract][Full Text] [Related]
19. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.
Váncsa A; Gergely L; Ponyi A; Lakos G; Németh J; Szodoray P; Dankó K
Joint Bone Spine; 2010 Mar; 77(2):125-30. PubMed ID: 20188618
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Ann Agric Environ Med; 2021 Mar; 28(1):189-192. PubMed ID: 33775087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
